Embryonic lethality and defective mammary gland development of activator‐function impaired conditional knock‐in Erbb3 V943R mice
Advanced Genetics · 2021
DOI: 10.1002/ggn2.10036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Genetics, 2021. Verfasst von Kate Senger und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology Genentech South San Francisco California USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
ERBB3 is a pseudokinase domain‐containing member of the ERBB family of receptor tyrosine kinases (RTKs). Following ligand binding, ERBB receptors homo‐ or hetero‐dimerize, leading to a head‐to‐tail arrangement of the intracellular kinase domains, where the “receiver” kinase domain of one ERBB is activated by the “activator” domain of the other ERBB in the dimer. In ERBB3, a conserved valine at codon 943 (V943) in the kinase C‐terminal domain has been shown to be important for its function as an “activator” kinase in vitro . Here we report a knock‐in mouse model where we have modified the endogenous Erbb3 allele to allow for tissue‐specific conditional expression of Erbb3 V943R ( Erbb3 CKI‐V943R ). Additionally, we generated an Erbb3 D850N ( Erbb3 CKI‐D850N ) conditional knock‐in mouse model where the conserved aspartate in the DFG motif of the pseudokinase domain was mutated to abolish any potential residual kinase activity. While Erbb3 D850N/D850N animals developed normally, homozygous Erbb3 V943R/V943R expression during development resulted in embryonic lethality. Further, tissue specific expression of Erbb3 V943R/V943R in the mammary gland epithelium following its activation using MMTV‐Cre resulted in delayed elongation of the ductal network during puberty. Single‐cell RNA‐seq analysis of Erbb3 V943R/V943R mammary glands showed a reduction in a specific subset of fibrinogen‐producing luminal epithelial cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology Genentech South San Francisco California USA.
- Department of Pathology Genentech South San Francisco California USA.
- GEMpath Inc. Longmont Colorado USA.
- SciGenom Labs Pvt Ltd Kochi Kerala India.
- Department of Bioinformatics and Computational Biology Genentech South San Francisco California USA.
- Department of Immunology Discovery Genentech South San Francisco California USA.
ORCID-Profile: Somasekar Seshagiri
Zitieren
APA
Senger, K., Yuan, W., Sagolla, M., Doerr, J., Bolon, B., Ziai, J., Sun, K. H., Warming, S., Roose-Girma, M., Zhang, N., Tam, L., Newman, R. J., Chaudhuri, S., Antony, A., Goldstein, L. D., Durinck, S., Jaiswal, B. S., Lafkas, D., Modrusan, Z., & Seshagiri, S. (2021). Embryonic lethality and defective mammary gland development of activator‐function impaired conditional knock‐in Erbb3 V943R mice. Advanced Genetics. https://doi.org/10.1002/ggn2.10036
Vancouver
Senger K, Yuan W, Sagolla M, Doerr J, Bolon B, Ziai J, et al. Embryonic lethality and defective mammary gland development of activator‐function impaired conditional knock‐in Erbb3 V943R mice. Advanced Genetics. 2021. doi:10.1002/ggn2.10036
BibTeX
@article{Senger2021,
author = {Senger, Kate and Yuan, Wenlin and Sagolla, Meredith and Doerr, Jonas and Bolon, Brad and Ziai, James and Sun, Kai-Hui and Warming, Soren and Roose-Girma, Merone and Zhang, Na and Tam, Lucinda and Newman, Robert J and Chaudhuri, Subhra and Antony, Aju and Goldstein, Leonard D and Durinck, Steffen and Jaiswal, Bijay S and Lafkas, Daniel and Modrusan, Zora and Seshagiri, Somasekar},
title = {Embryonic lethality and defective mammary gland development of activator‐function impaired conditional knock‐in Erbb3 V943R mice},
journal = {Advanced Genetics},
year = {2021},
doi = {10.1002/ggn2.10036}
}
EUVIMED